Efficacy and Tolerability of a New Non-Extrafine Formulation of Beclomethasone HFA-134a in Patients with Asthma: Comparison with Beclomethasone CFC

Author： Rocca-Serra J.P.

Publisher： Adis International

ISSN： 1173-2563

Source： Clinical Drug Investigation, Vol.22, Iss.10, 2002-01, pp. : 653-665

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Comparison of Fluticasone Propionate, 100µg Twice Daily, Administered Via a CFC and Non-CFC Propellant, HFA 134a, in Adult Patients with Asthma

By Stone D.W.G.

Clinical Drug Investigation, Vol. 21, Iss. 10, 2001-10 ,pp. : 695-703

Adis International

Access to resources Recommend Favorite

HFA-beclomethasone cost effective for asthma in the UK

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 376, 2002-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

HFA-beclomethasone delivers affordable symptom control in asthma

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 335, 2001-01 ,pp. : 34-34

Adis International

Access to resources Recommend Favorite

HFA-beclomethasone delivers affordable symptom control in asthma

Inpharma, Vol. 1, Iss. 1311, 2001-01 ,pp. : 5-6

Adis International

Access to resources Recommend Favorite

HFA-beclomethasone cost effective for asthma in the UK

Inpharma, Vol. 1, Iss. 1351, 2002-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite